Literature DB >> 12870234

[High incidence and complications of Clostridium difficile diarrhea among patients with renal diseases].

Patricia Herrera1, Alejandro Cotera, Alberto Fica, Teresa Galdo, Miriam Alvo.   

Abstract

BACKGROUND: Clostridium difficile is the main agent causing antimicrobial associated nosocomial diarrhea. Chronic renal failure is a risk factor for this type of diarrhea. AIM: To study the incidence and complications of Clostridium difficile diarrhea in a university hospital and among patients with renal diseases. PATIENTS AND METHODS: Retrospective review of all cases of Clostridium difficile diarrhea that occurred in a university hospital, between June 2000 and May 2001.
RESULTS: In the Nephrology Unit, 48 episodes of Clostridium difficile diarrhea occurred in 35 patients (7 cases per 100 discharges/year). This figure is higher than the global incidence in the hospital (0.53 cases per 100 discharges/year, p < 0.001). The mean age of the 33 patients with renal diseases was 63 years old and 17 of them were female. Their main diagnoses were chronic renal failure in hemodialysis in 48%, uremic syndrome in 36% and renal transplant in 6%. Seventy nine percent had a history of antimicrobial use (42% quinolones and 36% cephalosporins). In 3 patients, the only risk factor was chronic renal failure. Seventy five percent responded to metronidazole and in 27%, diarrhea recidivated, compared with a 6% recurrence rate in other units, p < 0.02). Eight patients died during hospital stay.
CONCLUSIONS: Among patients with renal diseases, Clostridium difficile is frequent and associated with a high recurrence rate and mortality. Chronic renal failure may be a risk factor for its development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12870234

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  5 in total

Review 1.  The Risks of Incident and Recurrent Clostridium difficile-Associated Diarrhea in Chronic Kidney Disease and End-Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis.

Authors:  Parkpoom Phatharacharukul; Charat Thongprayoon; Wisit Cheungpasitporn; Peter J Edmonds; Pailin Mahaparn; Jackrapong Bruminhent
Journal:  Dig Dis Sci       Date:  2015-05-19       Impact factor: 3.199

2.  Assessing control bundles for Clostridium difficile: a review and mathematical model.

Authors:  Laith Yakob; Thomas V Riley; David L Paterson; John Marquess; Archie Ca Clements
Journal:  Emerg Microbes Infect       Date:  2014-06-18       Impact factor: 7.163

3.  Clinical characteristics associated with the severity of Clostridium [Clostridioides] difficile infection in a tertiary teaching hospital from Mexico.

Authors:  Laura Tijerina-Rodríguez; Elvira Garza-González; Adrián Martínez-Meléndez; Rayo Morfín-Otero; Adrián Camacho-Ortiz; Esteban Gonzalez-Diaz; Hector Raul Perez-Gomez; Licet Villarreal-Treviño; Héctor Maldonado-Garza; Sergio Esparza-Ahumada; Eduardo Rodríguez-Noriega
Journal:  Biomed J       Date:  2021-02-23       Impact factor: 7.892

4.  Clostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation.

Authors:  Javier Pilcante; Patricio Rojas; Daniel Ernst; Mauricio Sarmiento; Mauricio Ocqueteau; Pablo Bertin; Maria García; Maria Rodriguez; Veronica Jara; Maria Ajenjo; Pablo Ramirez
Journal:  Rev Bras Hematol Hemoter       Date:  2015-08-19

5.  Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.

Authors:  Holly Yu; Nestor Flaster; Adrian Lopez Casanello; Daniel Curcio
Journal:  Braz J Infect Dis       Date:  2020-12-05       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.